The Weekly Roundup: April 22-26

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

ICYMI: US FDA Recently Approves Stelara Biosimilar Ustekinumab-aekn for Psoriasis, Psoriatic Arthritis

Last week, the US Food and Drug Administration approved biosimilar ustekinumab-aekn (Selarsdi; Alvotech and Teva) for psoriasis and PsA.

European Union Approves Bimekizumab to Treat HS

The European approval was based on data from the Phase III BE HEARD I and BE HEARD II trials.

QUIZ: Test Your Knowledge of Rosacea Treatment Modalities and the Therapeutic Landscape

Click here to read more and answer our quiz questions in recognition of Rosacea Awareness Month.

From Earth to Skin: Reviewing the Role of Environmental Factors in Dermatologic Conditions

This Earth Day, we are reviewing studies and research linking the role of the environment with various skin conditions.

Tristan Hasbargen, PA-C: Closure Types in Mohs Surgery and More

Hasbargen presented Mohs surgery pearls on closure types and pattern recognition at the 2024 Diversity in Dermatology meeting.

LC-OCT Demonstrates Potential For Rapid, Effective Visualization of Inflammatory Conditions Across Skin Types

LC-OCT provided quick, noninvasive assessment of skin conditions with detailed imaging aids diagnosis and treatment, especially for patients with darker skin types.

FDA Issues Complete Response Letter for Abeona's Pz-cel for Epidermolysis Bullosa

The CRL indicates that the timing proposed for data submission would not allow enough time for the FDA to complete its review by the May 25 PDUFA date.

Retinoic Acid, Vitamin A Demonstrates Role in Regulating Hair Follicles and Epidermal Stem Cells

In vitro studies demonstrated that retinoic acid aids stem cells in transitioning away from a state of flexibility in wound healing.

Jessner’s Lymphocytic Infiltration of the Skin Mimicking Rosacea: A Rare Case Presentation

Chinese clinical researchers recently presented a unique case of JLIS manifesting as erythematous papules and infiltrative plaques on the nose and upper jaw, resembling rosacea.

ASLAN Announces Positive Phase 2 Results of Eblasakimab in Dupilumab-Treated Patients With AD

Sixty percent of dupilumab-treated patients with AD treated with 400mg of eblasakimab weekly achieved EASI-90 after 16 weeks.

Ruxolitinib, Educational Initiatives for Managed Care Professionals Play Crucial Role in Optimizing Care in Atopic Dermatitis

Posters from the Academy of Managed Care Pharmacy annual meeting featured studies on atopic dermatitis.

US Central and European Commands Should Revisit Disallowance of Systemic Treatments for Deployed Individuals With Psoriasis, Eczema, Paper Argues

At present, deployed members of the military are not permitted to be receiving therapy with systemic therapies such as immunomodulators and biologics.

Facial Skin Cancer Surgery Yields Low and Improved Scores For Perceived Stigmatization, Body Image Concerns, and Psychosocial Distress

A review found that Mohs micrographic surgery and conventional excision yielded comparable patient reported outcomes.

Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers

In online discussion April 23, commissioners cited health care specifically among their reasons for supporting the ban.

Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients

Desai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.

Patients With Hidradenitis Suppurativa Have Increased Odds of Respiratory Disease, According to Study Findings

Researchers conducted a population-based study examining a sample of patients with HS during hospital admissions.

Upadacitinib Outperforms Dupilumab in Primary and Secondary End Points in Head-to-Head AD Study

In LEVEL-UP, upadacitinib demonstrated superiority over dupilumab in achieving EASI-90 and little to no itch at week 16.

Biologic Therapy Linked to Increased Density of Demodex Mites and Prevalence of Demodicosis in Patients With Psoriasis vs Controls

A cross-sectional study revealed an increase and heightened prevalence of Demodex and demodicosis in individuals with psoriasis receiving biologic therapy.

Addressing Disparities in Skin-Aging Prevention Among Women of Color

A recent survey covered topics including skin-aging prevention, care-seeking behavior, trust in professionals, and more.

QUIZ RECAP: Test Your Knowledge of Rosacea Treatment Modalities and the Therapeutic Landscape

Earlier this week, we shared our third Rosacea Awareness Month quiz. Review the answers and your responses below.

Colorimetric Scale Offers Practical Classification in Clinical Assessment of Skin of Color

Skin cancer risk classification lacks reliability for darker skin tones and fails in evaluating cutaneous medical conditions or cosmetic interventions, according to creators of the scale.

Optical Coherence Tomography in Preoperative Mapping of BCC: A Novel Approach to Optimizing Mohs Micrographic Surgery

Study findings suggest OCT's effectiveness in accurately diagnosing and mapping BCC, with a high predictive capability for Mohs surgery requirements.

Clinician and Patient Perspective: Tapinarof Cream for Plaque Psoriasis

Mona Shahriari, MD, and a plaque psoriasis patient provide insights into the mechanism of action and benefits of tapinarof cream 1% as a nonsteroidal topical.